N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effect
Authors:
Open Access
- 5 June 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 22 (9) , 2520-2524
Abstract
Background. There are conflicting results regarding the effectiveness of N-acetylcysteine (NAC) in attenuating contrast-induced nephropathy (CIN). NAC administration independently reduces serum creatinine, potentially confounding studies utilizing creatinine-based endpoints. Albuminuria is a marker of renal injury and spot urine albumin: creatinine ratios (ACR) reflect 24-h urine albumin excretion. We performed a pre-specified secondary analysis from our published negative randomized control trial of NAC for prevention of CIN, to determine if NAC administration reduces albuminuria after contrast exposure following cardiac catheterization. Methods. We included study patients who had paired urine specimens obtained pre- and post-cardiac catheterization. Baseline characteristics were compared using the chi square test or Mann–Whitney U-test, as appropriate. Changes in ACR were evaluated using binomial exact test. The effect of NAC on post-cardiac catheterization changes in ACR ratio was evaluated by ordinal logistic regression. Results. A total of 125 patients met inclusion criteria (pre- and post-catheterization urinalysis within 7 days). Baseline characteristics neither differ between NAC and placebo groups, nor were they different from those who were excluded. Among the patients receiving NAC, 10.7% improved their ACR ratio and 7.1% worsened; in contrast, in patients on placebo only 4.3% improved, while 21.7% worsened ( P = 0.015). Change in ACR ratio was not associated with change in kidney function as measured by calculated creatinine clearance or GFR. Conclusions. The results of this analysis suggest NAC may attenuate contrast-induced glomerular or tubular injury, as defined by albumin excretion, and appears to be independent of any effect on creatinine-derived measures of kidney function. Larger studies are required to confirm this observation.Keywords
This publication has 16 references indexed in Scilit:
- Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysisThe American Journal of Medicine, 2004
- The cellular basis of albuminuriaClinical Science, 2004
- Correlation of Glomerular Permeability, Endothelial Injury, and Postoperative Multiple Organ DysfunctionSurgery Today, 2004
- A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effectAmerican Heart Journal, 2004
- Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy**The opinions, interpretations, conclusions, and recommendations expressed in this article are those of the authors and are not necessarily endorsed by the U.S. Army.The American Journal of Cardiology, 2003
- The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiographyKidney International, 2003
- Albumin to creatinine catio: A screening test with limitationsAmerican Journal of Kidney Diseases, 2002
- The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventionsJACC, 2002
- Microalbuminuria in the US population: Third National Health and Nutrition Examination SurveyAmerican Journal of Kidney Diseases, 2002
- Oxygen free radicals and contrast nephropathyAmerican Journal of Kidney Diseases, 1998